These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1294124)

  • 1. Immunotherapeutic modification of Escherichia coli peritonitis and bacteremia by tinospora cordifolia.
    Mathur SK
    J Postgrad Med; 1992; 38(2):102. PubMed ID: 1294124
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunotherapeutic modification of Escherichia coli peritonitis and bacteremia by Tinospora cordifolia.
    Thatte UM; Kulkarni MR; Dahanukar SA
    J Postgrad Med; 1992; 38(1):13-5. PubMed ID: 1512717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide nucleic acid antisense oligomer as a therapeutic strategy against bacterial infection: proof of principle using mouse intraperitoneal infection.
    Tan XX; Actor JK; Chen Y
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3203-7. PubMed ID: 16048926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality rate and bacteremia, endotoxin, and endothelin-1 levels in antibiotic therapy for E. coli septic peritonitis.
    Tsukada K; Katoh H; Shiojima M; Takenoshita S; Nagamachi Y
    APMIS; 1993 Feb; 101(2):97-100. PubMed ID: 8489768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a recombinant amino terminal fragment of bactericidal/permeability increasing protein in rodents challenged with LPS or E. coli bacteria.
    Kung AH; Ammons WS; Lin Y; Kohn FR
    Prog Clin Biol Res; 1994; 388():255-63. PubMed ID: 7831363
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of a recombinant endotoxin neutralizing protein in rabbits with Escherichia coli sepsis.
    Saladino R; Garcia C; Thompson C; Hammer B; Parsonnet J; Novitsky T; Siber G; Fleisher G
    Circ Shock; 1994 Feb; 42(2):104-10. PubMed ID: 8013061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of immunomodulatory activity of Suvarnamalini vasant, a generic Ayurvedic herbomineral formulation.
    Sangle V; Darp M; Nadkarni S
    Indian J Exp Biol; 2004 Jan; 42(1):115-6. PubMed ID: 15274492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of cephalosporin treatment of bacteremia due to CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli.
    Bin C; Hui W; Renyuan Z; Yongzhong N; Xiuli X; Yingchun X; Yuanjue Z; Minjun C
    Diagn Microbiol Infect Dis; 2006 Dec; 56(4):351-7. PubMed ID: 16934430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of anti-CD14 monoclonal antibody on clearance of Escherichia coli bacteremia and endotoxemia.
    Opal SM; Palardy JE; Parejo N; Jasman RL
    Crit Care Med; 2003 Mar; 31(3):929-32. PubMed ID: 12627007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Escherichia coli bacteremia resistant to ciprofloxacin].
    Alós JI; Rodríguez C; Amor E; Gómez Garcés JL
    Med Clin (Barc); 1991 Oct; 97(14):556-7. PubMed ID: 1753836
    [No Abstract]   [Full Text] [Related]  

  • 11. Value of antibiotics, corticosteroids, and peritoneal lavage in the treatment of experimental peritonitis.
    Sleeman HK; Diggs JW; Hayes DK; Hamit HF
    Surgery; 1969 Dec; 66(6):1060-6. PubMed ID: 4918608
    [No Abstract]   [Full Text] [Related]  

  • 12. Gentamycin reduces bacteremia and mortality rates associated with the treatment of experimental peritonitis with recombinant tissue plasminogen activator.
    van Goor H; de Graaf JS; Kooi K; Bleichrodt RP
    J Am Coll Surg; 1995 Jul; 181(1):38-42. PubMed ID: 7599769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of the bovine antimicrobial peptide indolicidin combined with piperacillin/tazobactam in experimental rat models of polymicrobial peritonitis.
    Ghiselli R; Giacometti A; Cirioni O; Mocchegiani F; Orlando F; Silvestri C; Di Matteo F; Abbruzzetti A; Scalise G; Saba V
    Crit Care Med; 2008 Jan; 36(1):240-5. PubMed ID: 18090372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of fluconazole in murine Candida albicans and bacterial C. albicans peritonitis and abscess formation.
    Sawyer RG; Adams RB; Rosenlof LK; May AK; Pruett TL
    J Med Vet Mycol; 1995; 33(2):131-6. PubMed ID: 7658305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of immunosuppression in obstructive jaundice by Tinospora cordifolia.
    Rege NN; Nazareth HM; Bapat RD; Dahanukar SA
    Indian J Med Res; 1989 Dec; 90():478-83. PubMed ID: 2697692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of therapeutic claims of Tinospora cordifolia: a review.
    Panchabhai TS; Kulkarni UP; Rege NN
    Phytother Res; 2008 Apr; 22(4):425-41. PubMed ID: 18167043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of reconstituted high-density lipoprotein in rabbit gram-negative bacteremia models.
    Hubsch AP; Casas AT; Doran JE
    J Lab Clin Med; 1995 Dec; 126(6):548-58. PubMed ID: 7490514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal infection due to extended-spectrum beta-lactamase-producing Escherichia coli: implications for antibiotic choice for spontaneous bacterial peritonitis.
    Paterson DL; Singh N; Gayowski T; Marino IR
    Clin Infect Dis; 1999 Mar; 28(3):683-4. PubMed ID: 10194100
    [No Abstract]   [Full Text] [Related]  

  • 19. Broad-spectrum beta-lactams for treating experimental peritonitis in mice due to Escherichia coli producing plasmid-encoded cephalosporinases.
    Vimont S; Aubert D; Mazoit JX; Poirel L; Nordmann P
    J Antimicrob Chemother; 2007 Nov; 60(5):1045-50. PubMed ID: 17804425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Microbiological studies in the treatment of peritonitis].
    Fedorov VD; Lizgunova AV; Nikitin AM
    Khirurgiia (Mosk); 1971 Jan; 47(1):52-60. PubMed ID: 4930586
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.